⚠ Intuitive Buys Back Its DistributorsHigh threat

Synektik (SNT) — threat to the moat

Intuitive just paid $533 million to take three countries off its distributors; Synektik's contract runs to 2031 and not beyond.

The clearest threat to Synektik is written in its supplier's quarterly report. On 1 March 2026 Intuitive Surgical acquired the da Vinci and Ion distribution businesses previously run by ab medica, Abex and Excelencia Robótica, paying about $533,1 million in cash, and assumed direct distribution in Italy, Spain, Portugal, Malta and San Marino1. Of the fair value it bought, $279,8 million was intangible and other assets and $218,0 million goodwill2: Intuitive paid mainly for relationships and a position, not for warehouses.

Intuitive purchase of southern European distributors, 1 Mar 2026 ($ m)533,1Cash paid279,8Intangible and other assets218,0Goodwill91,8ReceivablesIntuitive Surgical Form 10-Q, quarter to June 2026
Most of the price was for the franchise itself.

That is the price of a distributor's franchise when the manufacturer decides to own it. Synektik's whole market value was about 3,0 billion złoty at 24 September 20263, roughly $780 million at the Polish central bank's rate45.

The mitigating fact is the timing. Intuitive signed the annex extending Synektik to 31 December 2031 and adding Ukraine in February 20266, the month before it closed the southern European purchase. A manufacturer planning to take Poland direct in the near term would hardly add a country to the contract first.

Intuitive's own documents describe the southern European purchase as part of its forward-looking risks: it names its ability to integrate the acquisition of the da Vinci and Ion distribution businesses in Italy, Spain and Portugal, and the transition from a distributor to a direct sales model there7. A manufacturer that has just learnt how to absorb three distributors has a template for the fourth.

Watch the annexes rather than the accounts. Any shortening of the term or narrowing of the territory would be the first sign; the contract has a little over five years to run, and the question returns with each year that passes.

References
  1. ReportedOn 1 March 2026 Intuitive Surgical acquired the da Vinci and Ion distribution businesses previously run by ab medica, Abex and Excelencia Robótica, paying about $533,1 million in cash, and assumed direct distribution in Italy, Spain, Portugal, Malta and San Marino.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
  2. ReportedOf the fair value it bought, $279,8 million was intangible and other assets and $218,0 million goodwill: Intuitive paid mainly for relationships and a position, not for warehouses.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
  3. ReportedSynektik's whole market value was about 3,0 billion złoty at 24 September 2026, roughly $780 million at the Polish central bank's rate.
    Biznesradar, Synektik market-value ratios - market capitalisation 3 007 370 971 złoty at 352,60 złoty. — September 2026 · publ. 24 September 2026 · source ↗
  4. ReportedSynektik's whole market value was about 3,0 billion złoty at 24 September 2026, roughly $780 million at the Polish central bank's rate.
    National Bank of Poland, table A mid rate for the US dollar, 24 September 2026: 3,8570. — 24 September 2026 · publ. 24 September 2026 · source ↗
  5. Moat Explorer calcSynektik's whole market value was about 3,0 billion złoty at 24 September 2026, roughly $780 million at the Polish central bank's rate.
    Moat Explorer calculation from Synektik's reported figures (thousands of złoty unless stated). Market value: 352,60 złoty x 8 529 129 shares = 3 007,4 million złoty (about 3,0 billion złoty); at the NBP rate of 3,8570 = $779,7 million (about $780 million). Trailing revenue to June 2026: 681 598,6 - 482 060,1 + 733 427,1 = 932 965,6 (about 933 million złoty). Trailing continuing net profit: 126 019,2 - 85 705,2 + 137 952,7 = 178 266,7; over 8 529 129 shares = 20,90 złoty; P/E 352,60 / 20,90 = 16,9. Equipment and IT segment EBITDA over segment revenue: 187 190,7 / 631 915,5 = 29,6% (FY2025); 143 577,5 / 579 299,1 = 24,8% (FY2024); 98 943,8 / 410 834,1 = 24,1% (FY2023); 29 865,3 / 139 272,7 = 21,4% (FY2022); 18 636,4 / 100 878,6 = 18,5% (FY2021); 19 605,9 / 112 126,1 = 17,5% (FY2019). Radiopharmaceutical segment EBITDA margin: 16 061,3 / 52 937,4 = 30,3% (FY2025); 16 276,6 / 46 615,7 = 34,9% (FY2024). Recurring revenue, trailing: 374,7 / 59,8 = 6,3 times (September 2022 to June 2026); installed base 142 / 37 = 3,8 times. Recurring revenue per year-end robot: 311,3 / 113 = 2,75 million złoty (FY2025); 193,9 / 86 = 2,25 million złoty (FY2024). Procedures per year-end robot, FY2025: Poland 19 800 / 75 = 264; Czechia and Slovakia 12 500 / 38 = 329. Revenue per average employee: 681,6 / 221 = 3,08 million złoty. Export share: 183,7 / 681,6 = 27,0%. Equipment segment share of revenue excluding intragroup sales: 631,1 / 681,6 = 92,6% (about 93%). Intuitive products: 44,9% x 681,6 = 306,0 million złoty; other equipment, IT and service 681,6 - 306,0 - 50,5 = 325,1 million złoty. Synektik market value over the Estonian contract: 3 007,4 / 41 = 73 (roughly seventy). Dividend paid February 2026: 10,75 x 8 529 129 = 91,7 million złoty; dividend per share 10,75 / 0,45 = 23,9 times since 2021. Free cash flow: FY2025 78,3 - 17,4 = 60,9 million złoty; FY2024 89,6 - 44,9 = 44,7 million złoty. IT4KAN price over market value: 4,15 / 3 007,4 = 0,14%. Recurring revenue, April-June 2025: 103,6 / 1,26 = 82,2 million złoty. Backlog plus active offers at June 2026: 44,2 + 160,8 = 205,0 million złoty. NFZ spending per robotic operation: 59 / 2,1 = 28 thousand złoty (2022); 167 / 5,4 = 31 thousand złoty (2023); 300 / 11 = 27 thousand złoty (2024). NFZ-funded PET studies: 96,1 / 89,3 - 1 = 7,6% (about 8%); per scanner 96 100 / 37 = about 2 600. Affidea: 29,0% x 52,9 = 15,3 million złoty, against segment EBITDA of 16,1 million złoty. Synektik's installed base as a share of Intuitive's: 142 / 11 710 = 1,2%. Czech and Slovak installed base: 42 / 16 = 2,6 times. Equipment segment purchases from others: 100 - 80,2 - 6,8 = 13,0%. Years of exclusivity from September 2026 to 31 December 2031: about 5,3. Year-end P/E and P/S (market value at 30 September over net profit and revenue; continuing profit from FY2024): 122,8 / 9,136 = 13,4 and 122,8 / 134,8 = 0,91 (FY2019); 190,2 / 8,811 = 21,6 and 1,52 (FY2020); 252,5 / 8,384 = 30,1 and 1,96 (FY2021); 237,5 / 10,709 = 22,2 and 1,42 (FY2022); 516,9 / 52,452 = 9,9 and 1,16 (FY2023); 1 635,9 / 98,909 = 16,5 and 2,62 (FY2024); 2 149,3 / 126,019 = 17,1 and 3,15 (FY2025); market values from closing prices of 14,40 złoty, 22,30, 29,60, 27,85, 60,60, 191,80 and 252,00 x 8 529 129. — October 2018 - June 2026 · publ. September 2026 · source ↗
    Method: Arithmetic on figures reported in Synektik's financial statements, management board reports, factsheet and market data; operands shown in the source line.
  6. ReportedIntuitive signed the annex extending Synektik to 31 December 2031 and adding Ukraine in February 2026, the month before it closed the southern European purchase.
    Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
  7. ReportedIntuitive's own documents describe the southern European purchase as part of its forward-looking risks: it names its ability to integrate the acquisition of the da Vinci and Ion distribution businesses in Italy, Spain and Portugal, and the transition from a distributor to a direct sales model there.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
Sources
Generated September 24, 2026